KalshiVerifica disponibilitàKYC richiesto2% di commissioneDati di risoluzione verificatiDiscretamente calibratoProbabilità implicita attuale
Before Jan 1, 2032 59%In testa tra 6 esiti
Qualità del mercato
47 / 100
Bassa qualitàVolume 24h
81,9 €
Liquidità
5,7K €
Liquidità mediaSpread
5.0 pt
Spread moderatoDati di mercato
Aggiornato 13 minuti fa
14 mag 26, 02:00 UTC1 gen 28, 04:59 UTC
Trend
Mercati Correlati
Domande correlate per il contesto, non un confronto tra contratti equivalenti.
Will the FDA approve cytisinicline for smoking cessation?
KalshiWill the FDA approve CagriSema?
KalshiWill the FDA approve intismeran autogene (V940/mRNA-4157)?
KalshiWill FDA approve any mRNA vaccine against melanoma before 2028?
Manifold MarketsWill FDA approve any mRNA vaccine against any type of herpes simplex infection before 2028?
Manifold MarketsWill FDA approve any mRNA vaccine against any strain of influenza before 2028?
Manifold MarketsRegole
If the FDA approves midomafetamine / MDMA for PTSD for marketing the named outcome, then the market resolves to Yes.
Si regola tramite:Food and Drug Administration
- An approval is defined as:
- For new drugs: FDA issuance of an approval letter for a New Drug Application (NDA) or Biologics License Application (BLA) For already-marketed drugs seeking new indications: FDA approval of a supplemental NDA (sNDA) or supplemental BLA (sBLA) for the specific indication referenced For generic drugs: FDA approval of an Abbreviated New Drug Application (ANDA) For biosimilars: FDA approval of a 351(k) application
- The following constitute approvals that trigger the Payout Criterion:
- Standard approval (traditional approval based on clinical benefit) Accelerated approval (based on surrogate endpoints) Approval with Risk Evaluation and Mitigation Strategy (REMS) Approval with restricted distribution or indication limitations, except compassionate use/expanded access programs
- The following do NOT constitute approvals:
Mercati aperti
Health & Medicine
POLYMARKETHantavirus pandemic in 2026?
- No+0.4pt97%
- Yes-0.4pt3%
- Volume totale
- 15,7 Mln €
- Volume 24h
- 52,2K €
KALSHIMeasles cases in 2026?
- Above 4000+2.0pt99%
- Above 300099%
- Above 600061%
+2 altri esiti
- Volume totale
- 870,4K €
- Volume 24h
- 2,1K €
POLYMARKETNew pandemic in 2026?
- No-1.0pt93.1%
- Yes+1.0pt6.9%
- Volume totale
- 922,5K €
- Volume 24h
- 1,8K €
KALSHICyclosporiasis cases reported in the US in 2026?
- Above 18k99%
- Above 6k99%
- Above 10k99%
+12 altri esiti
- Volume totale
- 32,4K €
- Volume 24h
- 1,3K €
KALSHIWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- No97%
- Yes+0.4pt3%
- Volume totale
- 1,6 Mln €
- Volume 24h
- 933,9 €
KALSHIHealthcare AI adoption in September
- Above 43%87%
- Above 43.75%59%
- Above 45%14%
+4 altri esiti
- Volume totale
- 810,1 €
- Volume 24h
- 767 €
- FDA decision: Ivonescimab by Summit Therapeutics (in 2026)
- Measles cases in U.S. in 2026?
- Measles cases in U.S. by September 30?
- What will the average number of measles cases be during Trump's term?
- When will Beam Therapeutics submit a BLA for Risto-cel?
- Will the FDA approve any psychedelic substance for medical use this year?
- Pandemic in 2026?
- How many human screwworm cases will be reported in the United States in 2026?
- When will Heidi Overton be confirmed as Commissioner of the FDA?
- Which countries will have an Ebola case in 2026?
- Ebola: new country confirmed before October 1?
Domande frequenti
- Quali sono le probabilità attuali per Will the FDA approve MDMA for PTSD??
- Kalshi quota Before Jan 1, 2032 al 59% al 11 settembre 2026.
- Quando si risolve Will the FDA approve MDMA for PTSD??
- Will the FDA approve MDMA for PTSD? dovrebbe risolversi il 1 gennaio 2028.
- Come viene liquidato Will the FDA approve MDMA for PTSD??
- Kalshi liquida questo mercato come segue: If the FDA approves midomafetamine / MDMA for PTSD for marketing the named outcome, then the market resolves to Yes.